RARA CRAFT DATABASE for FDA Medical Devices
510(k)K221734

FDA DEVICE FACTS

Maxtec MaxO2 ME+p

Maxtec, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 1, 2023PRODUCT CODECCL

Indications for use

The subject device, MaxO2 ME+p, have added the feature of measuring and monitoring pressure. The indications are similar to the primary predicate K152659 Maxtec – MaxO2 ME for measuring oxygen concentration and the secondary predicate K992101, Caradyne - Criterion 40 for measuring and monitoring pressure.

Environment of Use The subject device, MaxO2 ME+p, has similar environments of use when compared to the primary predicate K152659 Maxtec – MaxO2 ME and the secondary predicate K992101, Caradyne - Criterion

40. However, the subject device is not intended for the home care setting like the secondary predicate. This difference does not raise different concerns of safety or effectiveness.

Population The subject device, MaxO2 ME+p, has similar patient population as the primary predicate K152659 Maxtec – MaxO2 ME and the secondary predicate K992101, Caradyne - Criterion 40. The K992101, Caradyne - Criterion 40 did not specify a patient population, but measurement of pressure would have included the same population as the subject device.

While it is not specified in the predicates, the population does not raise different concerns of safety or effectiveness.

Performance Specifications The subject device, MaxO2 ME+p, has similar performance specifications when compared to the secondary predicate K992101, Caradyne - Criterion 40.

There are differences in the pressure measurement range between the devices with the subject device limited to a maximum of 60 cmH2O and the predicate measures up to 99 cmH2O. The alarm setting ranges are also adjusted for this lower maximum pressure.

The alarm delay for the subject device is 3 seconds as compared to the predicate which can be up to 20 seconds. This difference does not raise different concerns of safety or effectiveness.

Non-clinical Testing We performed a number of tests to demonstrate that the proposed device performed as intended. Testing includes:

• AAMI ANSI ES 60601-1: 2005 +A1: 2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance

• IEC 60601-1-2: 2014 Collateral standard: Electromagnetic Disturbances - Requirements and Tests

• AIM Standard 7351731: 2017 Electromagnetic Immunity Test for Exposure to Radio Frequency Identification Readers

• IEC 60601-1-8: 2012 Collateral Standard: General requirements, tests and guidance for alarm systems in medical electrical equipment and medical electrical systems

• ISO 80601-2-55: 2018 Particular requirements for the basic safety and essential performance of respiratory gas monitors Biocompatibility Patient contacting materials were evaluated per:

• ISO 10993-5:2009 - Cytotoxicity

• ISO 10993-10:2010 – Sensitization and Irritation

• ISO 10993-11:2017 – Material Mediated Pyrogenicity

• ISO 10993-18:2020 – Chemical Characterization with a Toxicological Risk Assessment

• ISO 18562-2:2017 – Particulate Material

• ISO 18562-3:2017 – VOC with Toxicological Risk Assessment

Animal No animal testing was performed.

Clinical No human clinical testing was performed.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 19, 2026